Indoor mold exposure and lung immune reactions linked to Alzheimer-like brain changes

The Role of Aspergillus versicolor and the Th2 Lung-Brain Axis in Alzheimer's Disease-like Neuropathology

NIH-funded research Indiana University Indianapolis · NIH-11262817

This project looks at whether breathing a common indoor mold and the lung's allergic-type immune response can cause brain inflammation and Alzheimer-like changes in people exposed to mold or with asthma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis NIH-funded
Lab location1 site (Indianapolis, United States)
Project IDNIH-11262817 on NIH RePORTER

What this research studies

From a patient's perspective, scientists are studying a common indoor fungus called Aspergillus versicolor to see if breathing it triggers an allergic-type (Th2) immune response in the lungs that then affects the brain. Most of the work uses controlled exposures and immune and brain measurements in laboratory models, together with comparisons to limited human data suggesting a link between fungal pollutants and cognition. The team measures lung inflammation, immune cell changes, brain markers of neuroinflammation, and memory-related outcomes to map a potential lung-to-brain pathway. The goal is to find environmental and immune processes that might raise Alzheimer's risk and point to ways to reduce that risk.

Who could benefit from this research

Good fit: People with long-term indoor mold exposure, chronic allergic lung conditions such as asthma, or interest in environmental contributors to Alzheimer’s would be the most relevant candidates for related research or follow-up.

Not a fit: Patients whose Alzheimer’s risk is primarily genetic or who have no history of mold or allergic lung exposure may be less likely to benefit directly from these findings.

Why it matters

Potential benefit: If confirmed, this work could identify a preventable environmental trigger and an immune pathway that might be targeted to lower Alzheimer’s risk or guide new therapies.

How similar studies have performed: Small human studies and animal experiments have hinted that fungal or air pollution exposure can affect cognition, but the specific lung Th2-to-brain mechanism proposed here is relatively new and not yet proven in people.

Where this research is happening

Indianapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease treatmentAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.